BetterLife Pharma Inc.
BETRF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$29.12M
Close$
$-0.00
102.5% downside
Current Fair Value
102.5% downsideOvervalued by 102.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $29.12 Million |
|---|---|
| Enterprise Value | $30.66 Million |
| Earnings per Share | $-0.01 |
| Beta | 0.22 |
| Outstanding Shares | 162,322,501 |
Return
| Return on Equity | 32.03% |
|---|---|
| Return on Assets | -171.28% |
| Return on Invested Capital | 33.75% |
Valuation & Multiples
| P/E Ratio | -11.36 |
|---|---|
| PEG | -3.48 |
| Price to Sales | - |
| Price to Book Ratio | -0.18 |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -11.9 |
| Enterprise Value to Net Income | -9 |
| Total Debt to Enterprise | 0.08 |
| Debt to Equity | -0.23 |
Revenue Sources
No data
Last Earnings Call
Report Date
September 29, 2026
EPS Estimate
-
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About BetterLife Pharma Inc.
4 employees
CEO: Ahmad Doroudian
BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary ...